ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 56 filers reported holding ERASCA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,439 | -28.6% | 123,573 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $341,061 | -83.1% | 123,573 | -65.9% | 0.00% | -87.1% |
| Q2 2022 | $2,017,000 | -48.8% | 362,146 | -21.0% | 0.03% | -51.6% |
| Q1 2022 | $3,940,000 | -38.3% | 458,149 | +11.7% | 0.06% | -30.4% |
| Q4 2021 | $6,389,000 | -26.6% | 410,070 | -0.0% | 0.09% | -35.2% |
| Q3 2021 | $8,702,000 | – | 410,093 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AH Equity Partners Bio II, L.L.C. | 2,500,000 | $19,500,000 | 13.59% |
| ARCH Venture Management, LLC | 11,055,554 | $86,233,000 | 11.18% |
| EDBI Pte Ltd | 888,888 | $6,933,000 | 7.30% |
| Cormorant Asset Management, LP | 10,505,554 | $81,943,000 | 5.73% |
| AH Equity Partners V, L.L.C. | 50,000 | $390,000 | 2.53% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $2,438,000 | 2.18% |
| PFM Health Sciences, LP | 7,264,981 | $56,667,000 | 2.05% |
| Artal Group S.A. | 3,172,221 | $24,743,000 | 1.06% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 472,472 | $3,685,000 | 0.75% |
| EcoR1 Capital, LLC | 678,441 | $5,292,000 | 0.16% |